Topics

5/12/15
Researchers in the University at Buffalo’s Department of Neurology shared their findings through more than 30 presentations at the American Academy of Neurology’s 67th Annual Meeting.
4/29/15

The Howard Hughes Medical Institute has selected second-year University at Buffalo medical student Niema Razavian for its Medical Research Fellows Program.

4/23/15

Students in biomedical engineering and medicine are principals in the biotechnology venture that won a University at Buffalo entrepreneurship competition.

2/6/15
At the 2015 Medical Student Research Forum, aspiring physician-scientists showcased 45 original research projects they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
1/26/15

An international team led by Jonathan F. Lovell, PhD, assistant professor of biomedical engineering, has created a nanoparticle that may pave the way for “hypermodal” imaging — the ability to merge results from six different imaging modes using one contrast agent.

1/22/15
University at Buffalo researchers have designed a biomedical device that could make chemotherapy more efficient, reduce its side effects and improve how doctors treat some of the most deadly forms of cancer.
1/9/15

With the goal of improving chemotherapy, Jennifer A. Surtees, PhD, associate professor of biochemistry, will study what makes cancer cells sensitive or resistant to different DNA-damaging drugs.

10/6/14
Research led by a student in UB’s Medical Scientist Training Program is featured on the cover of the world’s most frequently cited cancer journal.
9/11/14

Wilma A. Hofmann, PhD, assistant professor of physiology and biophysics, will study cellular processes that cause high levels of unsaturated fats to increase the metastatic potential of prostate cancer cells.

8/21/14

Nearly 100 student-scientists from across the country showcased their original biomedical research during the 2014 Buffalo Summer Research Day.

4/4/14

Using tiny modified liposomes, University at Buffalo researchers are developing a chemotherapy delivery method that could improve cancer treatment, reduce its side effects and boost knowledge about the disease.

12/18/13

Actively seeking and successfully obtaining a creative mix of funding, Matthew J. Barth, MD, research assistant professor of pediatrics, is pursuing promising research aimed at helping children with B-cell non-Hodgkin lymphoma overcome resistance to treatment.

11/11/13

With the ultimate goal of designing new immunotherapeutic strategies, Richard B. Bankert, VMD, PhD, professor of microbiology and immunology, and his team are working to re-activate cancer-killing T cells in a tumor’s microenvironment.

10/25/13

Through her fledgling start-up firm, University at Buffalo researcher Kate Rittenhouse-Olson, PhD ’84, is turning a mouse antibody she created into a promising cancer-fighting therapy for humans.

8/30/13

More than 100 student scientists from across the country showcased their original research during this summer’s University at Buffalo Biomedical Research Day.

8/14/13
Piero R. Bianco, PhD, associate professor of microbiology and immunology, will use a $1.8 million grant to develop the first clear model of a biochemical DNA repair mechanism needed to stave off cancer.
4/26/13

The UB Clinical and Translational Science Institute showcased award-winning studies and novel technologies developed jointly by UB researchers and collaborators.

3/1/12

Kunle Odunsi, director of RPCI’s Center for Immunotherapy and UB professor of gynecology and obstetrics, is leading a phase 1 clinical trial of the dendritic cell vaccine.